Aerobic Biotaxy India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -76.23%
(FY 2020)
- Profit -61.70%
(FY 2020)
- Ebitda -168.62%
(FY 2020)
- Net Worth -34.45%
(FY 2020)
- Total Assets -4.96%
(FY 2020)
About Aerobic Biotaxy India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Daniel Wickham, Curtis Ashbeck, and Prema Shenoi serve as directors at the Company.
- CIN/LLPIN
U24232KA2012PTC064205
- Company No.
064205
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2012
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Aerobic Biotaxy India Private Limited offer?
Aerobic Biotaxy India Private Limited offers a wide range of products and services, including Laboratory Mixers, Vortexer, Dustbins, Garbage Bin.
Who are the key members and board of directors at Aerobic Biotaxy India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prema Shenoi  | Managing Director | 01-Jun-2012 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daniel Wickham  | Director | 05-Aug-2013 | Current |
| Curtis Ashbeck | Director | 05-Aug-2013 | Current |
Financial Performance of Aerobic Biotaxy India.
Aerobic Biotaxy India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 76.23% decrease. The company also saw a substantial fall in profitability, with a 61.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aerobic Biotaxy India?
In 2020, Aerobic Biotaxy India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biotaxy India Private LimitedActive 5 years 10 monthsCurtis Ashbeck and Prema Shenoi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aerobic Biotaxy India?
Unlock and access historical data on people associated with Aerobic Biotaxy India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aerobic Biotaxy India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aerobic Biotaxy India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
